ImmuneOncia Therapeutics Inc. clinical trials
A subsidiary of Yuhan Corporation
The registry lists 5 studies whose lead sponsor is ImmuneOncia Therapeutics Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.
Registry sponsor names on this page
- ImmuneOncia Therapeutics Inc.5 studies
Something wrong with this grouping? Tell us on the Yuhan Corporation page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Yuhan Corporation studies →
- A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard TherapyRecruitingNCT05276310Phase 1
Sponsor listed in the registry: ImmuneOncia Therapeutics Inc.
- A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid TumorRecruitingNCT06365840Phase 2
Sponsor listed in the registry: ImmuneOncia Therapeutics Inc.
- A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeActive, not recruitingNCT04414163Phase 2
Sponsor listed in the registry: ImmuneOncia Therapeutics Inc.
- A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory LymphomasCompletedNCT04306224Phase 1
Sponsor listed in the registry: ImmuneOncia Therapeutics Inc.
- Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid TumorsCompletedNCT03644056Phase 1
Sponsor listed in the registry: ImmuneOncia Therapeutics Inc.